A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Glymidine
Asunaprevir
The serum concentration of Eluxadoline can be increased when it is combined with Asunaprevir.
Glymidine
Venetoclax
The serum concentration of Eluxadoline can be increased when it is combined with Venetoclax.
Glymidine
Silibinin
The serum concentration of Eluxadoline can be increased when it is combined with Silibinin.
Glymidine
Paritaprevir
The serum concentration of Eluxadoline can be increased when it is combined with Paritaprevir.
Glymidine
Sacubitril
The serum concentration of Eluxadoline can be increased when it is combined with Sacubitril.
Glymidine
Naloxegol
Eluxadoline may increase the opioid antagonism activities of Naloxegol.
Glymidine
Methylnaltrexone
Eluxadoline may increase the opioid antagonism activities of Methylnaltrexone.
Glymidine
Tafamidis
The excretion of Eluxadoline can be decreased when combined with Tafamidis.
Glymidine
Favipiravir
The excretion of Eluxadoline can be decreased when combined with Favipiravir.
Glymidine
Ivosidenib
The excretion of Eluxadoline can be decreased when combined with Ivosidenib.
Glymidine
Pradigastat
The excretion of Eluxadoline can be decreased when combined with Pradigastat.
Glymidine
Letermovir
The excretion of Eluxadoline can be decreased when combined with Letermovir.
Glymidine
Avatrombopag
The excretion of Eluxadoline can be decreased when combined with Avatrombopag.
Glymidine
Apalutamide
The excretion of Eluxadoline can be decreased when combined with Apalutamide.
Glymidine
Baricitinib
The excretion of Eluxadoline can be decreased when combined with Baricitinib.
Glymidine
Cabotegravir
The excretion of Eluxadoline can be decreased when combined with Cabotegravir.
Glymidine
Ataluren
The excretion of Eluxadoline can be decreased when combined with Ataluren.
Glymidine
Alvimopan
The risk or severity of adverse effects can be increased when Eluxadoline is combined with Alvimopan.
Ginkgo biloba
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ubidecarenone is combined with Fenofibric acid.
Ginkgo biloba
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ubidecarenone is combined with Clofibride.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3